Impedimed Limited (IPD:ASX)


right-arrow Created with Sketch. -0.003 (-2%)
MCAP $156.9M
Last trade 13.43pm 26/02/2021 20mins delayed

Latest Announcements

24/02/2021IPDImpedimed Limited
22/02/2021 Price SensitivePSIPDImpedimed Limited
12/02/2021 Price SensitivePSIPDImpedimed Limited
28/01/2021 Price SensitivePSIPDImpedimed Limited
21/01/2021IPDImpedimed Limited
11/01/2021IPDImpedimed Limited
11/01/2021IPDImpedimed Limited
11/01/2021 Price SensitivePSIPDImpedimed Limited

Company Overview

ImpediMed Limited is an Australia-based company, which is a global provider of medical technology to measure, monitor and manage fluid status and body composition. The principal activities of the Company consist of the development, manufacture and sale of bioimpedance instruments and consumables, and the sale of electronic test and measurement devices. The Company's operating segments include Medical, and Test & Measurement. The Medical segment is a supplier of non-invasive medical devices to over two underserved markets: aiding in the subclinical assessment of individuals at risk of secondary lymphedema, and the monitoring of body composition and hydration. The medical cash-generating unit (CGU) is the core business of the Company. The Test & Measurement segment is a supplier of power precision testing and measuring equipment (T&M). The Company's geographical locations include Australia/rest of world (ROW) and North America.

IPD in the news

Search Previous Announcements